Anaptysbio (ANAB) Assets (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.53% |
| Dec 31, 2025 | 3.20% |
| Sep 30, 2025 | 5.32% |
| Jun 30, 2025 | -20.57% |
| Mar 31, 2025 | -12.77% |
| Dec 31, 2024 | -1.94% |
| Sep 30, 2024 | 15.45% |
| Jun 30, 2024 | 5.31% |
| Mar 31, 2024 | -10.29% |
| Dec 31, 2023 | -7.17% |
| Sep 30, 2023 | -5.76% |
| Jun 30, 2023 | -6.29% |
| Mar 31, 2023 | -9.60% |
| Dec 31, 2022 | -1.31% |
| Sep 30, 2022 | 2.43% |
| Jun 30, 2022 | -3.41% |
| Mar 31, 2022 | -2.78% |
| Dec 31, 2021 | 51.55% |
| Sep 30, 2021 | -0.52% |
| Jun 30, 2021 | 7.61% |
| Mar 31, 2021 | -4.83% |
| Dec 31, 2020 | 8.27% |
| Sep 30, 2020 | -4.23% |
| Jun 30, 2020 | -5.30% |
| Mar 31, 2020 | -2.52% |
| Dec 31, 2019 | -3.61% |
| Sep 30, 2019 | -5.97% |
| Jun 30, 2019 | -2.85% |
| Mar 31, 2019 | -2.90% |
| Dec 31, 2018 | -2.70% |
| Sep 30, 2018 | 70.95% |
| Jun 30, 2018 | -2.80% |
| Mar 31, 2018 | -4.41% |
| Dec 31, 2017 | 170.09% |
| Sep 30, 2017 | -6.49% |
| Jun 30, 2017 | -0.54% |
| Mar 31, 2017 | 110.86% |